P072 A 3-WEEK COURSE OF 80MG WEEKLY ADMINISTERED ADALIMUMAB AS A RESCUE THERAPY FOR PATIENTS WITH CROHN'S DISEASE WHO LOST RESPONSE TO 40MG WEEKLY: RELATIONSHIP WITH ADALIMUMAB TROUGH SERUM LEVELS
K. Karmiris, M. Noman, G. Paintaud, M. Ferrante, A. Duveau, D. Degenne, G. Van Assche, S. Vermeire, P. RutgeertsVolume:
2
Year:
2008
Language:
english
DOI:
10.1016/s1873-9954(08)70083-1
File:
PDF, 74 KB
english, 2008